is mounjaro a glp-1 receptor agonist How Helping People With Obesity Lose Weight GLP-1 receptor agonists | How

Mounjaro has butted in a bit with coupon programs, but still only was approved by health insurers 50% of the time for off label indications

As part of our weight management services, we prescribe medications such as semaglutide GLP-1 and Zepbound to help patients achieve and maintain a healthy weight, when appropriate

Data Availability Statement The data presented in the study are openly available in online databases.

Ueda P, Sderling J, Wintzell V, Svanstrm H, Pazzagli L, Eliasson B, et al

Employers offering weight-loss coverage rose in 2026 from 17% in 2024 Canadian employers are broadening access to glucagon-like peptide-1 (GLP-1) drugs for weight loss, with the share offering that coverage rising to 37 percent in 2026 from 17 percent in 2024

For those whove struggled for years, they represent a powerful tool for finally gaining control and feeling a sense of progress that once seemed out of reach